From 1987 to 1990, Mr. Himmel was a managing director of Rothschild Inc., where he worked with the famed investor, Wilbur Ross, as a financial advisor to unsecured creditors and security holders, restructuring troubled companies. From 1983 to 1986, he was Vice Chairman and Executive Vice President of Jeffrey Martin, Inc., an over-the-counter pharmaceutical company founded by his father, Martin Himmel.
Mr. Himmel is a former member of the board of directors of The Wharton School at the University of Pennsylvania Undergraduate Executive Board (1999-2010), and is a member of the board of directors of The Consumer Healthcare Products Association, the industry trade organization for the over-the-counter pharmaceutical and dietary supplements industries, a member of its Finance Committee, and Chairman of its Audit Committee (1991-Present).
He received a B.S. in Economics from the Wharton School of Finance and Commerce at the University of Pennsylvania (1975), a Master of Science in Taxation from Bentley College (1978), and is a former member of the American Institute of Certified Public Accountants (AICPA) and New York State Society of Certified Public Accountants.
About The Frost Group:
The Frost Group has invested more than $175 million in companies and technologies since it started in 2006. Dr. Phillip Frost is Chairman of Israel-based Teva Pharmaceuticals; Chairman of Ladenburg Thalmann Financial Services, Inc.; Chairman of OPKO Health, Inc.; and, Chairman of PROLOR Biotech, Inc.
ChromaDex, Inc. is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an expanding pipeline of new ingredients, including its branded pTeroPure®
|SOURCE ChromaDex Corporation|
Copyright©2010 PR Newswire.
All rights reserved